Live feed
·
INSIDERFilingvia Quantisnow
Tevogen Inc. logo

Tevogen (TVGN) director Podlogar received 240,000 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Susan M Podlogar (director at Tevogen Inc., TVGN) reported that they received 240,000 shares on Dec 23, 2024. After these transactions the filing shows 433,923 shares held directly.

Reporting person
Podlogar Susan M
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Dec 23, 2024Grant or award (A)Common Stock1+240,000--433,923 direct

Holdings before and after

  • Common Stock: 193,923 to 433,923 direct

Footnotes from the filing

  1. 1. Represents a grant of restricted stock units ( RSUs ) under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments beginning on January 1, 2025, provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Podlogar report in this TVGN Form 4?

Susan M Podlogar (director at Tevogen Inc., TVGN) reported that they received 240,000 shares on Dec 23, 2024. After these transactions the filing shows 433,923 shares held directly.

How many TVGN shares does Podlogar hold after this filing?

The filing shows 433,923 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for TVGN

Earlier insider filings at TVGN

Quantisnow market dataNASDAQ
Tevogen Inc. logo
TVGN
Tevogen Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2022
Get push alerts for TVGN

Follow TVGN and get a push notification the moment its next story breaks.

Full TVGN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVGN (Tevogen Inc.) and more on Quantisnow.